Clinical Trial Update: Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating letrozole for recurrent or metastatic endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED